Evaluation of the genotoxic effects of pyrimethamine, an antimalarial drug, in the in vivo mouse

Teratogenesis Carcinogenesis and Mutagenesis

Volumn 20, Issue 2, 2000, Pages 65-71

  Vijayalaxmi, K K ^a   Vishalakshi, M ^a  

^a MANGALORE UNIVERSITY   (India)

Author keywords

Bone marrow; Genotoxicity; Micronucleus; Pyrimethamine; Transplacental

Indexed keywords

PYRIMETHAMINE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; FETUS; FETUS LIVER; GENOTOXICITY; MICRONUCLEUS TEST; MOUSE; NONHUMAN; PLACENTAL TRANSFER; PRIORITY JOURNAL;

ANIMALS; ANTIMALARIALS; BONE MARROW; CYCLOPHOSPHAMIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROCYTES; FEMALE; LIVER; MALE; MATERNAL-FETAL EXCHANGE; MICE; MICRONUCLEI, CHROMOSOME-DEFECTIVE; MICRONUCLEUS TESTS; MUTAGENICITY TESTS; PREGNANCY; PYRIMETHAMINE;

ANIMALIA;

EID: 0033966423     PISSN: 02703211     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6866(2000)20:2<65::AID-TCM2>3.0.CO;2-K     Document Type: Article

References (29)

1. Cavallito JC, Nichol CA, Brenckman WD, Deangelis RL Jr, Stickney DR, Simmons WS, Sigel CW. Liquid soluble inhibitors of dihydrofolate reductase. I. Kinetics, tissue distribution and extent of metabolism of pyrimethamine, metoprine and etoprine in the rat, dog and man. Drug Metab Disp 1978;6:329-337.
2. Tsunematsu K, Shimoda M, Hayama T. Effect of folic acid on pharmacokinetics of pyrimethamine in rats. Cong Anom 1992;32:357-365.
3. Sullivan CE, Takacs E. Comparative teratogenicity of pyrimethamine in rats and hamsters. Teratology 1971;4:205-210.
4. Yamamoto Y, Ohnishi M, Kokue E, Hayama T, Aoyama H, Keneda M, Teramoto S. Pyrimethamine teratogenesis by short term administration in Goetingen miniature pig. Cong Anom 1984;24:83-87.
5. Tangapregassom AM, Tangapregassom MJ, Horvath C, Trecul M, Boucher-Ehrensperger M , Petter C. Vascular anomalies and pyrimethamine induced malformations in the rat. Teratog Carcinogen Mutagen 1985;5:55-62.
6. Horvath C, Compagnon A, Petter C. Effect teratogene de la pyrimethamine chez le rat. Prevention in vivo par le folinate de calcium. CR Soc Biol 1988;182:158-166.
7. Satoh K, Kojima N, Furuno M, Kokue E, Hayama T. Ameliorative effect of folic acid on pyrimethamine teratogenesis in pigs. Cong Anom 1991;31:325-328.
8. Baranov VS, Chebotar NA. Mutagenic effects of preovulatory administration of pyrimethamine on preimplantation rat embryos. Teratalog Genot 1980;14:20-24.
9. Ohta T, Moriya M, Kaneda Y, Watanabe K, Miyazawa T, Sugiyama F, Shirasu Y. Mutagenecity screening of feed additives in the microbial system. Mutat Res 1980;77:21-30.
10. Crebelli R, Conti G, Conti L, Carere A. In vitro studies with nine known or suspected spindle poisons: results in tests for chromosome malsegregation in Aspergillus nidulans. Mutagenesis 1991;6:131-136.
11. Albertini S. Analysis of nine known or suspected spindle poisons for mitotic chromosome malsegregation using Saccharomyces cerevisiae D61. Mutagenesis 1990;5:453-459.
12. Fasunon OD, Uwaifo AO. Prophage induction by 4 antimalaria drugs (Daraprim, Fansidar, Nivaquine and Camoquine) and in combination with aflatoxin B1. Mutat Res 1989;222:311-316.
13. Egeli U, Erdogan G. The clastogenic effect of pyrimethamine (Daraprim) on human chromosomes in lymphocyte cultures. Cell Biol Toxicol 1991;7:347-356.
14. Antoccia A, Degrassi F, Battistoni A, Ciliutti P, Tanzarella C. In vitro micronucleus test with kinetochore staining: evaluation of test performance. Mutagenesis 1991;6:319-324.
15. Adler D, Kliesch P, Van Hummelen, Kirsch-Volders M. Mouse micronucleus tests with known and suspect spindle poisons: results from two laboratories. Mutagenesis 1991;8:47-55.
16. Ono T, Yoshimura H. Analysis of micronucleus induction of pyrimethamine in in vitro CHL cells and in in vivo mouse bone marrow cells. Mutagenesis l996;2:85-88.
17. Gudi R, Jing Xu, Thilagar A. Assessment of the in vivo aneuploidy/micronucleus assay in mouse bone marrow cells with 16 chemicals. Environ Mol Mutagen 1992;20:106-116.
18. Schmid W. Chemical mutagen testing in in vivo somatic mammalian cells. Agents Actions 1973;3:77-85.
19. Seetharam Rao KP, Abdul Rahiman M, Koranne SP. Bovine albumin as a substitute for fetal calf serum in the micronucleus test. Int Symp Recent Trends Med Genet (Ab) 1983;28.
20. Nakamura M, Fort FL, Kikuchi Y. Fetal liver micronucleus assay in mice of 5-fluorouracil and related compounds. Mutat Res 1993;281:29-34.
21. Hassard TH. Understanding biostatistics. Mosby Yearbook, 1981.
22. Leopardi P, Zijno A, Bassani D, Pacchierotti F. In vivo studies on chemically induced aneuploidy in mouse somatic and germinal cells. Mutat Res 1993;287:119-130.
23. Lynch AM, Parry JM. The cytochalasin B micronucleus/kinetochore assay, in vitro studies with 10 suspected aneugens. Mutat Res 1993;287:71-86.
24. Ono T, Norrimatsu M, Yoshimura H. Induction of chromosome aberrations by pyrimethamine in cultured Chinese hamster (CHL) cells. Mutat Res 1994;323:197-201.
25. Sutherland GR, Baker E, Fratine E. Excess thymidine induces folate sensitive fragile sites. Am J Med Genet 1985;22:433-443.
26. Tucker JD, Vanderlaon M, Kwan TC, Moore DH, Felton JS. Effects of diet and folate on levels of micronucleated polychromatic erythrocytes. Mutat Res 1993;301:19-26.
27. Anderson DF. Pharmetton JM, Rankin JHG. The measurement of foetal drug clearance in near term sheep: indomethacin. J Pharmacol Exp Ther 1980;213:100-104.
28. Cole RJ, Taylor N, Cole J, Arlett CF. Short term tests for transplacentally active carcinogen micronucleus formation in fetal and maternal mouse erythroblasts. Mutat Res 1981;80: 141-157.
29. Kindig D, Garriott ML, Parton JW, Brunny JD, Beyers, JE. Diphenylhydantoin is not genotoxic in a battery of short term cytogenetic assays: Teratog Carcinog Mulagen 1992;12:43-50.